University of Maryland School of Medicine researchers have uncovered a previously unknown molecular pathway that is critical to understanding cardiac arrhythmia and other heart muscle problems. Understanding the basic science of heart and muscle function could open the door to new treatments.
Researchers warn of a looming health crisis in the wake of rising mortgage delinquencies and home foreclosures. The study is the first long-term survey of the impact the current housing crisis is having on older Americans. The study focused on adults over 50 and found high rates of depression among those behind in their mortgage payments and a higher likelihood of making unhealthy financial tradeoffs regarding food and needed prescription medications.
Surgeons at the University of Maryland Medical Center have transplanted the first lungs treated in the United States with an experimental repair process before transplantation, to evaluate the efficacy of repairing lungs that might otherwise have been passed over as unsuitable for organ donation.
The University of Maryland School of Medicine has found that mobile phone software is effective for the self-management of diabetes. The study published in September in Diabetes Care is one of the first to examine the new field of mobile health.
A team led by the University of Maryland School of Medicine Institute for Genome Sciences unraveled the genomic code of the E. coli that caused the German outbreak that began in May.
Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating the most common type of non-Hodgkin's lymphoma.
A multicenter clinical trial led by a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women. The study will help researchers determine if an experimental drug, entinostat, can reprogram tumor cells to express a protein called an estrogen receptor to make them sensitive to hormone therapy.
University of Maryland researchers found that Parkinson's patients who did low intensity training on a treadmill for a longer duration improved their walking more than patients who walked at a higher-intensity for a shorter time.
A leading panel of neurologists, including a University of Maryland physician, has issued new recommendations to help doctors offer the most up-to-date treatments for people with diabetic neuropathy.
BP oil spill caused significant psychological impact even to nearby communities not directly touched by oil, Univ. of Maryland School of Medicine and Univ. of Florida researchers report.
Researchers from the Univ. of Maryland School of Medicine are coordinating an international team of scientists working to identify genes or gene variants that may make a person more likely to have an ischemic stroke.
African American patients and those with lower socioeconomic status have more advanced disease and greater disability when they seek treatment from Parkinson’s specialists, according to a University of Maryland study.
The University of Maryland Medical Center has been named by the Leapfrog Group a "Top Hospital of the Decade" for patient safety and quality of care. The award recognizes the medical center’s inclusion on the Leapfrog Top Hospital list every year since its inception in 2006. The medical center shares the Top Hospital of the Decade honor with only one other hospital—Virginia Mason Medical Center in Seattle, Washington. The awards were presented on November 30, 2010, in Washington, D.C.
University of Maryland study finds that increased coverage of specially trained physicians, pharmacists and respiratory therapists can improve survival in intensive care.
An inhaled anti-rejection drug can dramatically improve survival after a lung transplant, according to a study according to a study conducted at the University of Pittsburgh and led by lung disease specialists who are now at the University of Maryland in Baltimore.
A new study concludes that widespread screening for cardiovascular risk by measuring blood levels of C-reactive protein should not be advocated, because CRP appears to be tightly linked to traditional risk factors for heart disease rather than being an independent risk factor.
A national team of researchers has demonstrated for the first time that an experimental radioactive compound can show images of heart damage up to 30 hours after a brief interruption of blood flow and oxygen.
A new project tests telemedicine consultations for women with high risk pregnancies who live in outlying/rural areas. There aren't many high risk specialists in these areas, so the patients have to drive several hours to meet with a perinatalogist, adding to the stress of an already stressful pregnancy.
Angela H. Brodie, Ph.D., professor of pharmacology and experimental therapeutics at the University of Maryland School of Medicine, has won the prestigious Charles F. Kettering Prize for her pioneering work in developing aromatase inhibitors.
A multi-center study of a tablet that combines two hypertension drugs shows significant benefit for people with hard-to-control blood pressure. The combination reduced systolic blood pressure to a desirable level in 77 percent of study participants.
Contrary to conventional thinking, a kidney transplant can significantly improve the heart function of people on dialysis who also have a serious form of heart failure.
Using laughter-provoking movies to gauge the effect of emotions on cardiovascular health, researchers have shown for the first time that laughter is linked to healthy function of blood vessels.
Steven D. Munger, PhD, assistant professor of Anatomy and Neurobiology at the University of Maryland School of Medicine has received the 2003 Presidential Early Career Award for Scientists and Engineers.
Edward A. Sausville, M.D., Ph.D., a leader in cancer research at the National Cancer Institute,will become associate director of clinical research at the University of Maryland Greenebaum Cancer Center.
A new program aims to reduce the rate of stroke through aggressive treatment of "mini-strokes," also known as TIA (transient ischemic attack). About one-third of TIA patients will later have a larger stroke.
Kevin J. Cullen, M.D., a highly regarded leader in cancer research and treatment at the Lombardi Cancer Center at Georgetown University, has been chosen as director of the University of Maryland Greenebaum Cancer Center.
Pilot project in Baltimore tests telemedicine screenings in local mall. Special camera takes picture looking for glaucoma and diabetic retinopathy. Pictures sent via Internet to eye specialists for evaluation.
Edmond F. Notebaert, a nationally recognized health system leader who headed the Children"šs Hospital of Philadelphia Health System for 13 years, has been named the next President and CEO of the University of Maryland Medical System, effective September 2003.
"It is my opinion that Florence Nightingale suffered from bipolar disorder, a mental illness characterized by alternating highs and lows," says Katherine L. Wisner, M.D., M.S., professor of Psychiatry.
Couples looking for permanent contraception now have a new option other than tubal ligation or vasectomy. Doctors at the University of Maryland Medical Center are now offering Essure, a non-surgical procedure for women.
New stent-assisted coiling procedure means some patients with wide-neck aneurysms may avoid brain surgery. Previously some patients would need open-cranial surgery; but, for some, surgery might be too risky. New stent offers life-saving option.
Photodynamic therapy, which uses a red laser and a light-sensitive drug to destroy cancer cells without harming normal tissue, represents a promising new treatment option for patients with throat or oral cancers, a voice and swallowing specialist says.
Patients with severe leg injuries have similar outcomes regardless of whether they have surgery to repair their leg or undergo amputation, a new study finds. Both groups had high levels of disability and psychological distress.
Alan R. Shuldiner, M.D., the head of the Division of Endocrinology, Diabetes and Nutrition at the University of Maryland School of Medicine, has received a four-year, $10.6 million grant from the National Institutes of Health to study how genes and lifestyle factors influence people's risk of developing cardiovascular disease.
The University of Maryland School of Medicine Center for Vaccine Development has been awarded a $22 million NIH contract to evaluate vaccines against a wide range of infections that pose a threat to public health, including possible bioterror agents such as anthrax and smallpox.
In the movies, a venomous snakebite victim is often saved by a quick thinking companion who applies a tourniquet, cuts the skin and sucks out the poison. It makes for a dramatic scene, but it is bad medicine, according to an article authored by physicians at the University of Maryland School of Medicine and the Rocky Mountain Poison Center.
One of first scientific studies to evaluate psychological and spiritual effects on the immune system kicked off at the Institute of Human Virology.
Transplant surgeons at the University of Maryland Medical Center say they have successfully reduced barriers to kidney transplantation for African-Americans to cut the median waiting time for transplant in half. Their achievement stems from a comprehensive program that includes patient education and efforts to increase living donation and improve overall kidney graft survival.
As part of a national multi-center study, researchers at the University of Maryland Greenebaum Cancer Center in Baltimore are testing a custom-made vaccine for low-grade non-Hodgkin's lymphoma that uses each patient's own tumor cells to combat the cancer.
A non-surgical outpatient procedure called TheraSphere that uses millions of microscopic glass beads imbedded with radiation to treat inoperable liver cancer is adding months to patients' lives, specialists at the University of Maryland Greenebaum Cancer Center report.
Although grandmothers are an important source of support for young mothers, a new study from the University of Maryland School of Medicine finds that preschool children living in three-generation households (with an adolescent mother and a grandmother) do not have fewer behavioral and developmental problems than other preschool children.
The Institute of Human Virology, a center of the University of Maryland Biotechnology Institute, this month opens two innovative clinical trials, one utilizing a pharmaceutically-produced compound based on a naturally-occurring substance (called chemokines) that can block the HIV virus and halt the progression of AIDS.
Cancer specialists at the University of Maryland Greenebaum Cancer Center report that TheraSphere, a new approach used to treat inoperable liver cancer, has resulted in a 38 percent success rate and that side effects have been minimized by modifying the procedure. Findings to be presented at RSNA Conference on Wednesday, Nov. 28.
The University of Maryland Joslin Diabetes Center will be one of 10 centers nationwide studying a potential new tool that, if effective, would be "music to the fingertips" of anyone diagnosed with diabetes -- a painless, needle-free glucose-monitoring device.
The University of Maryland Greenebaum Cancer Center has begun two innovative stem cell transplant studies that look at ways to bolster a patient's immune system in an effort to protect the patient from infection and make the transplant itself more effective.
Preliminary results indicate that giving men chemotherapy with a particular drug before hormonal therapy may potentially be an effective strategy in treating prostate cancer that has come back following surgery or radiation therapy. Results of the study were presented June 5, 2001 at the American Urological Association's annual meeting by oncologists at the University of Maryland Greenebaum Cancer Center in Baltimore.
The University of Maryland Greenebaum Cancer Center has begun to study a new drug called Iressa that has shown promising results in treating lung and prostate cancer patients. The new study, sponsored by the National Cancer Institute, is looking at the drug's effectiveness in treating kidney cancer patients.
Cancer specialists from the University of Maryland Greenebaum Cancer Center report that early results of a new treatment for inoperable liver cancer, known as TheraSphere, are promising at the 37th annual meeting of the American Society of Clinical Oncologists on May 15.
The University of Maryland Greenebaum Cancer Center will be the first site in the world to offer leukemia patients a new drug known as MS-275, which is also being studied by the National Cancer Institute for advanced solid tumors.
He conquered Britain, crushed a plot to overthrow his government, and endured a variety of physical ailments, but the Roman Emperor Claudius could not survive a plate of poisonous mushrooms dished out by a scheming, power-hungry wife. The murder of Claudius is the focus of this year's historical diagnosis conference at the University of Maryland School of Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right